SC 13G Filing

Company

Citius Pharmaceuticals, Inc.

Filed

January 26, 2018

Accession Number

0000919574-18-000626

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →